Vertex Pharmaceuticals Inc vs Johnson & Johnson
VRTX vs JNJ — side-by-side comparison from reported financials. VRTX leads 4, JNJ leads 5 of 9 comparable metrics.
Vertex Pharmaceuticals Inc
VRTX · Healthcare
$510.00+1.34%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | VRTX | JNJ |
|---|---|---|
| Price | $510.00 | $261.79 |
| Market cap | $129B | $631B |
| Revenue (TTM) | $12.6B | $97.9B |
| Revenue growth | +10.3% | +5.6% |
| Net margin | 35.0% | 21.5% |
| Free cash flow | $3.80B | $22.2B |
| Net cash (debt) | — | ($27.8B) |
| 1-year price return | +22.9% | +37.0% |
| P/E | 29.3 | 29.9 |
| P/E vs own history (cheap-side %) | 29% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | 23% | 26% |
| CV checks passed | 9 of 10 | 10 of 10 |
| Employees | 6,400 | 140,800 |
Full résumé-style profiles: VRTX CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.